Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex
Open Access
- 4 January 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 8, 899
Abstract
Caffeine is the most widely used psychoactive drug, bolstering attention and normalizing mood and cognition, all functions involving cerebral cortical circuits. Whereas studies in rodents showed that caffeine acts through the antagonism of inhibitory A1 adenosine receptors (A1R), neither the role of A1R nor the impact of caffeine on human cortical neurons is known. We here provide the first characterization of the impact of realistic concentrations of caffeine experienced by moderate coffee drinkers (50 μM) on excitability of pyramidal neurons and excitatory synaptic transmission in the human temporal cortex. Moderate concentrations of caffeine disinhibited several of the inhibitory A1R-mediated effects of adenosine, similar to previous observations in the rodent brain. Thus, caffeine restored the adenosine-induced decrease of both intrinsic membrane excitability and excitatory synaptic transmission in the human pyramidal neurons through antagonism of post-synaptic A1R. Indeed, the A1R-mediated effects of endogenous adenosine were more efficient to inhibit synaptic transmission than neuronal excitability. This was associated with a distinct affinity of caffeine for synaptic versus extra-synaptic human cortical A1R, probably resulting from a different molecular organization of A1R in human cortical synapses. These findings constitute the first neurophysiological description of the impact of caffeine on pyramidal neuron excitability and excitatory synaptic transmission in the human temporal cortex, providing adequate ground for the effects of caffeine on cognition in humans.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007440, PTDC/NEU-NMC/4154/2016)
- European Research Council (StG “BrainSignals”)
- Horizon 2020 Framework Programme (agreement no. 604102 “Human Brain Project”)
- Seventh Framework Programme (EU MSCA-ITN CognitionNet FP7-PEOPLE-2013-ITN 607508)
- National Alliance for Research on Schizophrenia and Depression
This publication has 80 references indexed in Scilit:
- Caffeine Consumption Prevents Diabetes-Induced Memory Impairment and Synaptotoxicity in the Hippocampus of NONcZNO10/LTJ MicePLOS ONE, 2012
- Caffeine-induced synaptic potentiation in hippocampal CA2 neuronsNature Neuroscience, 2011
- A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: Data from the Nurses’ Health Study IIEpilepsia, 2010
- Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2Areceptor knockout mice with microarray profilingPhysiological Genomics, 2009
- Physiological roles of A1and A2Aadenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeineAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Fast Inhibition of Glutamate-Activated Currents by CaffeinePLOS ONE, 2008
- Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterizationNeuropharmacology, 2004
- Modification of adenosine modulation of synaptic transmission in the hippocampus of aged ratsBritish Journal of Pharmacology, 2000
- Blood-brain barrier transport of caffeine: Dose-related restriction of adenine transportLife Sciences, 1982
- Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthinesLife Sciences, 1981